
TEXT
ONLY FACULTY
EDUCATION
RESEARCH
PATIENT CARE
REFRACTIVE SURGERY
LINKS
HOME
|
![]() |
![]() |
|
![]() |
![]() |
![]() |
Patient Care Clinical Trials |
|
![]() Glaucoma Service at the University of Washington
![]() GLAUCOMA is a leading cause of blindness in the U.S. and the world, and may be the greatest cause of irreversible but preventable blindness in the world. RISK FACTORS for glaucoma include:
Advanced
age is an important risk factor, since glaucoma usually develops in
those above age 50, especially above age 65. If you are above age 60 you
should have your eyes examined by an ophthalmologist every year, even if
you are not having any trouble seeing. However, there are less common types
of glaucoma that affect infants and young people. African-Americans
are affected earlier (by as much as a decade on average) and more severely
by glaucoma than are white people, in general. Glaucoma is the leading cause
of blindness in people of African-American ancestry. A family
history of glaucoma (especially among brothers, sisters, parents, or
children) puts a person at a higher risk to have glaucoma. Other less-important
risk factors include diabetes mellitus, myopia (nearsightedness), retinal
vein occlusion, and chronic use of corticosteroid medications.TREATMENT of glaucoma usually starts with eyedrops that lower eye pressure. If medicines don't work well, eye pressure may be lowered by laser surgery to improve access to the drain of the eye (Peripheral Iridotomy or Iridoplasty) or to improve drain function (Laser Trabeculoplasty). Incisional surgery must be done sometimes, to bypass the poorly-functioning drain of the eye (Trabeculectomy). In some cases a plastic tube that drains eye fluid to the back of the eye must be implanted (Glaucoma Drainage Device) to lower eye pressure. Often cataracts occur in people who have glaucoma, and these may be removed surgically if appropriate. At the University of Washington Eye Center, glaucoma specialists Philip P. Chen, MD, Anuja Bhandari, MD, and Raghu Mudumbai, MD, see patients and perform surgery; please call (206) 598-4011 to schedule an appointment. Doctor Chen is also doing research on a wide variety of topics in glaucoma, including visual field testing using several different computerized perimeters; retinal nerve fiber layer measurement with the Nerve Fiber Analyzer; comparison of new eyedrops for glaucoma; effect of anti-scarring medicines on glaucoma surgery; and results of glaucoma surgery. FOR FURTHER INFORMATION, click on the following links: American
Academy of Ophthalmology (to find an ophthalmologist, and for more information); Glaucoma
Research Foundation (for additional information); National
Eye Institute (NEI) (for national research projects involving glaucoma.
Select Clinical Trials
Database, then search the Table of Contents (by
NEI-Disease Program Area) |
||||
![]() |
![]() |
||
|
© 1997-2007 University of Washington Department of Ophthalmology Return to Top of Page University of Washington School of Medicine Home Page University of Washington Home Page Ophthalmology Home Page |